to use recruiting platform for pulmonary embolism trial

By staff writers

March 6, 2023 -- Artificial intelligence (AI) software developer will use its Viz Recruit platform to help enroll patients in the National Institute of Health-funded Pulmonary Embolism-Thrombus Removal with Catheter-Directed Thrombolysis (PE-TRACT) clinical trial.

The trial will explore the efficacy of catheter-directed therapy for patients at intermediate risk of PE compared with the use of anticoagulants alone and will enroll 500 patients across 30 to 50 sites, according to the firm.

Copyright © 2023

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking